You just read:

Jazz Pharmaceuticals Announces First Patient Enrolled in Phase 2 Clinical Trial Evaluating Defibrotide for the Prevention of Acute Graft-versus-Host Disease

News provided by

Jazz Pharmaceuticals plc

23 Feb, 2018, 13:30 GMT